Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Premenopause | 67 | 2022 | 1039 | 7.430 |
Why?
|
Breast Neoplasms | 186 | 2024 | 21188 | 7.170 |
Why?
|
Nurses | 58 | 2023 | 2501 | 5.410 |
Why?
|
Gonadal Steroid Hormones | 21 | 2023 | 708 | 2.680 |
Why?
|
Carotenoids | 9 | 2021 | 620 | 2.480 |
Why?
|
Postmenopause | 45 | 2023 | 2519 | 2.430 |
Why?
|
Estrogens | 18 | 2021 | 1536 | 2.390 |
Why?
|
Prolactin | 14 | 2019 | 627 | 2.230 |
Why?
|
Estrone | 11 | 2022 | 234 | 1.730 |
Why?
|
Sex Hormone-Binding Globulin | 10 | 2023 | 554 | 1.710 |
Why?
|
Receptors, Estrogen | 29 | 2022 | 2252 | 1.670 |
Why?
|
Diet | 36 | 2023 | 8088 | 1.580 |
Why?
|
Risk Factors | 176 | 2024 | 74976 | 1.550 |
Why?
|
Metabolomics | 13 | 2023 | 1675 | 1.530 |
Why?
|
Hyperinsulinism | 3 | 2023 | 402 | 1.520 |
Why?
|
Case-Control Studies | 79 | 2023 | 22296 | 1.440 |
Why?
|
Prospective Studies | 118 | 2023 | 54962 | 1.370 |
Why?
|
Anti-Mullerian Hormone | 8 | 2022 | 420 | 1.300 |
Why?
|
Menopause, Premature | 4 | 2023 | 124 | 1.250 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2021 | 268 | 1.240 |
Why?
|
Vegetables | 7 | 2022 | 1199 | 1.210 |
Why?
|
Erythrocyte Membrane | 2 | 2020 | 438 | 1.150 |
Why?
|
Menopause | 15 | 2023 | 1656 | 1.140 |
Why?
|
Fruit | 6 | 2022 | 1165 | 1.140 |
Why?
|
Female | 280 | 2024 | 397515 | 1.130 |
Why?
|
Reproductive History | 6 | 2022 | 210 | 1.100 |
Why?
|
Diet, Vegetarian | 4 | 2023 | 181 | 1.070 |
Why?
|
Estradiol | 15 | 2023 | 1952 | 0.980 |
Why?
|
beta Carotene | 4 | 2015 | 523 | 0.950 |
Why?
|
Receptors, Progesterone | 17 | 2022 | 1159 | 0.940 |
Why?
|
Middle Aged | 177 | 2023 | 223737 | 0.930 |
Why?
|
Dietary Fats | 6 | 2020 | 2002 | 0.920 |
Why?
|
Adult | 182 | 2023 | 223851 | 0.900 |
Why?
|
Fatty Acids | 3 | 2020 | 1812 | 0.830 |
Why?
|
Humans | 300 | 2024 | 768970 | 0.830 |
Why?
|
Proportional Hazards Models | 37 | 2023 | 12562 | 0.830 |
Why?
|
Feeding Behavior | 11 | 2021 | 3205 | 0.810 |
Why?
|
Breast | 14 | 2023 | 1976 | 0.810 |
Why?
|
Parity | 10 | 2022 | 931 | 0.800 |
Why?
|
Body Size | 7 | 2021 | 463 | 0.780 |
Why?
|
Ovarian Neoplasms | 17 | 2022 | 4919 | 0.780 |
Why?
|
Tandem Mass Spectrometry | 12 | 2023 | 1197 | 0.770 |
Why?
|
Body Mass Index | 39 | 2023 | 13055 | 0.730 |
Why?
|
Adiposity | 8 | 2022 | 1895 | 0.720 |
Why?
|
Chromatography, Liquid | 9 | 2023 | 997 | 0.720 |
Why?
|
Diet Therapy | 1 | 2021 | 150 | 0.690 |
Why?
|
Endometrial Neoplasms | 4 | 2023 | 1386 | 0.680 |
Why?
|
Follow-Up Studies | 51 | 2023 | 39394 | 0.680 |
Why?
|
Diabetes Mellitus, Type 2 | 14 | 2023 | 12253 | 0.660 |
Why?
|
Osteoprotegerin | 1 | 2020 | 179 | 0.660 |
Why?
|
Tea | 4 | 2021 | 289 | 0.650 |
Why?
|
Flavonoids | 2 | 2019 | 447 | 0.640 |
Why?
|
Vitamin D | 9 | 2023 | 3311 | 0.640 |
Why?
|
Coffee | 4 | 2021 | 594 | 0.630 |
Why?
|
Exercise | 13 | 2023 | 5954 | 0.630 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2019 | 360 | 0.580 |
Why?
|
Progesterone | 6 | 2021 | 752 | 0.580 |
Why?
|
Xanthophylls | 3 | 2013 | 95 | 0.580 |
Why?
|
Dietary Fiber | 3 | 2016 | 767 | 0.570 |
Why?
|
Receptor, erbB-2 | 7 | 2022 | 2606 | 0.570 |
Why?
|
Lutein | 3 | 2013 | 123 | 0.550 |
Why?
|
Hormones | 5 | 2022 | 870 | 0.550 |
Why?
|
Aptamers, Nucleotide | 1 | 2018 | 163 | 0.550 |
Why?
|
Genome-Wide Association Study | 23 | 2023 | 12801 | 0.550 |
Why?
|
Reactive Oxygen Species | 2 | 2016 | 2149 | 0.550 |
Why?
|
Cohort Studies | 54 | 2023 | 41808 | 0.550 |
Why?
|
Alcohol Drinking | 11 | 2021 | 4045 | 0.540 |
Why?
|
Caffeine | 3 | 2020 | 703 | 0.540 |
Why?
|
Breast Feeding | 5 | 2019 | 1364 | 0.530 |
Why?
|
Endometriosis | 6 | 2023 | 874 | 0.530 |
Why?
|
Life Style | 13 | 2022 | 3931 | 0.530 |
Why?
|
Motor Activity | 7 | 2021 | 2713 | 0.530 |
Why?
|
Breast Diseases | 5 | 2021 | 442 | 0.520 |
Why?
|
Logistic Models | 22 | 2023 | 13318 | 0.510 |
Why?
|
Testosterone | 12 | 2023 | 2493 | 0.510 |
Why?
|
Risk | 20 | 2020 | 9621 | 0.500 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 7 | 2022 | 2276 | 0.490 |
Why?
|
Lipid Metabolism | 2 | 2020 | 1904 | 0.490 |
Why?
|
Analgesics | 4 | 2018 | 1071 | 0.490 |
Why?
|
Inflammation Mediators | 2 | 2020 | 1890 | 0.470 |
Why?
|
Luteal Phase | 6 | 2018 | 138 | 0.470 |
Why?
|
Weight Gain | 7 | 2020 | 2359 | 0.460 |
Why?
|
Incidence | 33 | 2023 | 21547 | 0.430 |
Why?
|
Eating | 2 | 2019 | 1542 | 0.430 |
Why?
|
Polymorphism, Single Nucleotide | 23 | 2023 | 16053 | 0.430 |
Why?
|
4-Butyrolactone | 1 | 2013 | 60 | 0.430 |
Why?
|
Germ Cells | 3 | 2022 | 644 | 0.420 |
Why?
|
Phenols | 2 | 2014 | 526 | 0.410 |
Why?
|
Dairy Products | 3 | 2021 | 490 | 0.410 |
Why?
|
Lignans | 1 | 2013 | 84 | 0.410 |
Why?
|
United States | 48 | 2023 | 73186 | 0.400 |
Why?
|
Ferritins | 2 | 2014 | 600 | 0.390 |
Why?
|
Glucocorticoids | 1 | 2021 | 2167 | 0.390 |
Why?
|
Phthalic Acids | 2 | 2014 | 487 | 0.380 |
Why?
|
Aspirin | 6 | 2022 | 3135 | 0.380 |
Why?
|
Women's Health | 9 | 2024 | 2081 | 0.380 |
Why?
|
C-Peptide | 3 | 2023 | 443 | 0.380 |
Why?
|
Insulin Resistance | 2 | 2022 | 3982 | 0.380 |
Why?
|
Epidemiologic Studies | 8 | 2023 | 677 | 0.380 |
Why?
|
Neoplasms, Glandular and Epithelial | 4 | 2016 | 489 | 0.370 |
Why?
|
Vitamins | 5 | 2022 | 1638 | 0.370 |
Why?
|
Genetic Predisposition to Disease | 21 | 2023 | 18068 | 0.370 |
Why?
|
Metabolome | 5 | 2023 | 1009 | 0.370 |
Why?
|
Anticarcinogenic Agents | 1 | 2012 | 251 | 0.360 |
Why?
|
Risk Assessment | 31 | 2024 | 24333 | 0.360 |
Why?
|
Acetaminophen | 4 | 2014 | 556 | 0.350 |
Why?
|
Health Surveys | 7 | 2020 | 4055 | 0.350 |
Why?
|
Prognosis | 23 | 2022 | 30046 | 0.340 |
Why?
|
Obesity | 10 | 2023 | 13091 | 0.340 |
Why?
|
Benzhydryl Compounds | 2 | 2014 | 944 | 0.340 |
Why?
|
Ovulation | 2 | 2020 | 181 | 0.330 |
Why?
|
Genetic Variation | 8 | 2021 | 6611 | 0.320 |
Why?
|
Proteomics | 2 | 2022 | 3914 | 0.310 |
Why?
|
Nuts | 2 | 2021 | 264 | 0.300 |
Why?
|
Environmental Pollutants | 3 | 2014 | 1296 | 0.300 |
Why?
|
Aged | 58 | 2023 | 171786 | 0.300 |
Why?
|
Nutrition Assessment | 3 | 2021 | 740 | 0.300 |
Why?
|
Multivariate Analysis | 14 | 2021 | 12095 | 0.300 |
Why?
|
Menarche | 7 | 2021 | 538 | 0.300 |
Why?
|
Drug Utilization | 1 | 2014 | 1191 | 0.290 |
Why?
|
Reproducibility of Results | 15 | 2023 | 20245 | 0.290 |
Why?
|
Odds Ratio | 14 | 2023 | 9684 | 0.290 |
Why?
|
Lipids | 4 | 2022 | 3345 | 0.290 |
Why?
|
Androgens | 5 | 2019 | 1285 | 0.290 |
Why?
|
Environmental Exposure | 5 | 2022 | 4544 | 0.280 |
Why?
|
Dehydroepiandrosterone Sulfate | 4 | 2019 | 241 | 0.280 |
Why?
|
Leisure Activities | 2 | 2021 | 310 | 0.280 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2014 | 1363 | 0.280 |
Why?
|
Folic Acid | 4 | 2019 | 1338 | 0.280 |
Why?
|
Antioxidants | 1 | 2015 | 1673 | 0.280 |
Why?
|
Multifactorial Inheritance | 5 | 2023 | 1423 | 0.280 |
Why?
|
Risk Reduction Behavior | 4 | 2021 | 1119 | 0.280 |
Why?
|
Specimen Handling | 2 | 2022 | 708 | 0.270 |
Why?
|
Environmental Monitoring | 1 | 2013 | 1469 | 0.270 |
Why?
|
Meat | 3 | 2014 | 588 | 0.270 |
Why?
|
Mammary Glands, Human | 4 | 2016 | 202 | 0.270 |
Why?
|
Anthocyanins | 2 | 2019 | 80 | 0.270 |
Why?
|
Vitamin A | 3 | 2015 | 611 | 0.270 |
Why?
|
Longitudinal Studies | 14 | 2022 | 14794 | 0.270 |
Why?
|
Age Factors | 18 | 2021 | 18435 | 0.260 |
Why?
|
Sterilization, Tubal | 1 | 2006 | 78 | 0.260 |
Why?
|
Ascorbic Acid | 2 | 2022 | 658 | 0.250 |
Why?
|
Linear Models | 6 | 2020 | 5891 | 0.250 |
Why?
|
Mammography | 10 | 2024 | 2434 | 0.240 |
Why?
|
Adolescent | 32 | 2022 | 89244 | 0.240 |
Why?
|
Cross-Sectional Studies | 16 | 2023 | 26395 | 0.230 |
Why?
|
Colorectal Neoplasms | 6 | 2023 | 6982 | 0.230 |
Why?
|
Dehydroepiandrosterone | 3 | 2019 | 259 | 0.230 |
Why?
|
Work Schedule Tolerance | 2 | 2019 | 553 | 0.230 |
Why?
|
Germ-Line Mutation | 3 | 2021 | 1887 | 0.230 |
Why?
|
Energy Intake | 2 | 2022 | 2146 | 0.220 |
Why?
|
Lysophosphatidylcholines | 2 | 2022 | 77 | 0.220 |
Why?
|
Oxidative Stress | 4 | 2016 | 3139 | 0.220 |
Why?
|
Confidence Intervals | 5 | 2020 | 2932 | 0.220 |
Why?
|
Menstrual Cycle | 5 | 2022 | 546 | 0.210 |
Why?
|
Persea | 1 | 2023 | 17 | 0.210 |
Why?
|
Dietary Carbohydrates | 2 | 2020 | 896 | 0.210 |
Why?
|
Brassica | 1 | 2022 | 39 | 0.210 |
Why?
|
Beverages | 3 | 2021 | 819 | 0.210 |
Why?
|
Self Report | 6 | 2022 | 3773 | 0.210 |
Why?
|
Primary Prevention | 3 | 2016 | 1187 | 0.210 |
Why?
|
BRCA1 Protein | 2 | 2021 | 1156 | 0.210 |
Why?
|
Pregnancy | 15 | 2023 | 30265 | 0.200 |
Why?
|
Fabaceae | 1 | 2022 | 103 | 0.200 |
Why?
|
Plant Oils | 1 | 2023 | 199 | 0.200 |
Why?
|
Mothers | 4 | 2022 | 2209 | 0.200 |
Why?
|
Sweetening Agents | 2 | 2021 | 290 | 0.200 |
Why?
|
Cortisone | 1 | 2022 | 90 | 0.200 |
Why?
|
Weight Loss | 2 | 2020 | 2721 | 0.200 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2018 | 1536 | 0.190 |
Why?
|
Diet Records | 2 | 2020 | 426 | 0.190 |
Why?
|
Neoplasm Staging | 9 | 2021 | 11262 | 0.190 |
Why?
|
Radioimmunoassay | 4 | 2016 | 862 | 0.190 |
Why?
|
Disease Susceptibility | 5 | 2019 | 1794 | 0.190 |
Why?
|
Isoleucine | 1 | 2021 | 112 | 0.190 |
Why?
|
Carcinoma, Lobular | 2 | 2016 | 480 | 0.190 |
Why?
|
Pregnanediol | 1 | 2021 | 18 | 0.190 |
Why?
|
Exfoliation Syndrome | 1 | 2022 | 113 | 0.190 |
Why?
|
Vitamin D Deficiency | 2 | 2023 | 1388 | 0.190 |
Why?
|
Hypolipidemic Agents | 1 | 2005 | 609 | 0.180 |
Why?
|
Body Weight | 5 | 2020 | 4628 | 0.180 |
Why?
|
Cause of Death | 6 | 2022 | 3721 | 0.180 |
Why?
|
Receptors, Androgen | 2 | 2019 | 1091 | 0.180 |
Why?
|
Ovarian Function Tests | 1 | 2020 | 11 | 0.180 |
Why?
|
Rosacea | 1 | 2021 | 60 | 0.180 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2021 | 118 | 0.180 |
Why?
|
Estrogen Replacement Therapy | 4 | 2018 | 1209 | 0.180 |
Why?
|
Drinking Behavior | 1 | 2021 | 103 | 0.180 |
Why?
|
Hyperlipidemias | 1 | 2005 | 773 | 0.180 |
Why?
|
Glycemic Index | 2 | 2020 | 400 | 0.180 |
Why?
|
Young Adult | 26 | 2022 | 60131 | 0.180 |
Why?
|
Carcinogens, Environmental | 1 | 2020 | 70 | 0.170 |
Why?
|
Melatonin | 2 | 2016 | 670 | 0.170 |
Why?
|
Cyclooxygenase 2 | 2 | 2022 | 597 | 0.170 |
Why?
|
Insulin | 3 | 2020 | 6610 | 0.170 |
Why?
|
Carbonated Beverages | 1 | 2021 | 210 | 0.170 |
Why?
|
Pseudouridine | 1 | 2020 | 19 | 0.170 |
Why?
|
Sphingomyelins | 1 | 2020 | 105 | 0.170 |
Why?
|
Ownership | 1 | 2022 | 344 | 0.170 |
Why?
|
Cardiovascular Diseases | 7 | 2023 | 15661 | 0.170 |
Why?
|
Sunburn | 1 | 2021 | 156 | 0.170 |
Why?
|
Leucine | 1 | 2021 | 548 | 0.170 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2020 | 104 | 0.170 |
Why?
|
Coronary Disease | 3 | 2022 | 5919 | 0.170 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 1263 | 0.160 |
Why?
|
Epidemiologic Methods | 2 | 2021 | 1328 | 0.160 |
Why?
|
Thyroid Neoplasms | 3 | 2022 | 2360 | 0.160 |
Why?
|
Radon | 1 | 2020 | 91 | 0.160 |
Why?
|
Tissue Array Analysis | 2 | 2021 | 551 | 0.160 |
Why?
|
Body Height | 3 | 2020 | 1569 | 0.160 |
Why?
|
Ceramides | 1 | 2020 | 203 | 0.160 |
Why?
|
Pyridoxal Phosphate | 1 | 2019 | 123 | 0.160 |
Why?
|
Survival Analysis | 6 | 2021 | 10115 | 0.160 |
Why?
|
Seasons | 2 | 2016 | 1524 | 0.150 |
Why?
|
Adult Children | 1 | 2019 | 104 | 0.150 |
Why?
|
DNA Copy Number Variations | 3 | 2022 | 2055 | 0.150 |
Why?
|
Cyclooxygenase 1 | 1 | 2018 | 98 | 0.150 |
Why?
|
Phosphatidylcholines | 1 | 2020 | 406 | 0.150 |
Why?
|
Nutrition Surveys | 2 | 2018 | 1738 | 0.150 |
Why?
|
Carbon | 2 | 2019 | 672 | 0.150 |
Why?
|
Milk | 1 | 2021 | 438 | 0.150 |
Why?
|
Chronobiology Disorders | 1 | 2019 | 73 | 0.150 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2016 | 1093 | 0.150 |
Why?
|
Phenylhydrazines | 1 | 2018 | 28 | 0.150 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 906 | 0.150 |
Why?
|
Succinimides | 1 | 2018 | 83 | 0.150 |
Why?
|
Periodontal Diseases | 1 | 2021 | 455 | 0.140 |
Why?
|
Aged, 80 and over | 15 | 2021 | 59739 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
Bayes Theorem | 5 | 2023 | 2360 | 0.140 |
Why?
|
Dietary Supplements | 3 | 2022 | 3443 | 0.140 |
Why?
|
Air Pollutants | 2 | 2022 | 2915 | 0.140 |
Why?
|
Uric Acid | 1 | 2023 | 806 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 529 | 0.140 |
Why?
|
Food Analysis | 1 | 2017 | 103 | 0.140 |
Why?
|
Membrane Proteins | 1 | 2014 | 7885 | 0.140 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2016 | 31 | 0.140 |
Why?
|
Colonic Polyps | 1 | 2022 | 557 | 0.140 |
Why?
|
Vitamin B Complex | 1 | 2019 | 299 | 0.140 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1120 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 278 | 0.140 |
Why?
|
Retinoid X Receptors | 1 | 2016 | 91 | 0.130 |
Why?
|
Diet, Mediterranean | 2 | 2020 | 748 | 0.130 |
Why?
|
Dinoprostone | 1 | 2019 | 597 | 0.130 |
Why?
|
beta-Carotene 15,15'-Monooxygenase | 2 | 2013 | 12 | 0.130 |
Why?
|
Glaucoma, Open-Angle | 1 | 2023 | 742 | 0.130 |
Why?
|
Keratin-6 | 1 | 2015 | 15 | 0.130 |
Why?
|
Neoplasms | 3 | 2023 | 22389 | 0.130 |
Why?
|
Gout | 1 | 2023 | 621 | 0.130 |
Why?
|
Inflammation | 6 | 2023 | 10868 | 0.130 |
Why?
|
Keratin-5 | 1 | 2015 | 43 | 0.130 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2884 | 0.130 |
Why?
|
BRCA2 Protein | 1 | 2021 | 803 | 0.130 |
Why?
|
Hypertension | 4 | 2023 | 8617 | 0.130 |
Why?
|
Vitamin B 12 | 1 | 2019 | 529 | 0.130 |
Why?
|
Triglycerides | 2 | 2022 | 2464 | 0.130 |
Why?
|
Macular Degeneration | 1 | 2023 | 1016 | 0.130 |
Why?
|
Women's Health Services | 1 | 2016 | 88 | 0.130 |
Why?
|
Diet Surveys | 1 | 2019 | 1160 | 0.130 |
Why?
|
Longevity | 2 | 2020 | 1077 | 0.120 |
Why?
|
Depression | 3 | 2022 | 8231 | 0.120 |
Why?
|
Models, Statistical | 5 | 2017 | 5110 | 0.120 |
Why?
|
Leiomyoma | 1 | 2020 | 644 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 628 | 0.120 |
Why?
|
Statistics as Topic | 3 | 2016 | 2360 | 0.120 |
Why?
|
Parturition | 1 | 2018 | 456 | 0.120 |
Why?
|
Biological Availability | 1 | 2015 | 392 | 0.120 |
Why?
|
Blood Glucose | 3 | 2020 | 6435 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2019 | 8664 | 0.120 |
Why?
|
Exercise Therapy | 1 | 2021 | 939 | 0.110 |
Why?
|
Receptors, Calcitriol | 1 | 2016 | 361 | 0.110 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2023 | 1106 | 0.110 |
Why?
|
Laparoscopy | 4 | 2022 | 2055 | 0.110 |
Why?
|
Fee-for-Service Plans | 1 | 2019 | 714 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1255 | 0.110 |
Why?
|
Acrylamide | 1 | 2013 | 59 | 0.110 |
Why?
|
Empirical Research | 1 | 2013 | 119 | 0.110 |
Why?
|
Vitamin D-Binding Protein | 1 | 2014 | 130 | 0.110 |
Why?
|
Child Abuse | 1 | 2022 | 1091 | 0.110 |
Why?
|
Tumor Burden | 2 | 2016 | 1913 | 0.100 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2017 | 1943 | 0.100 |
Why?
|
Gene Expression | 3 | 2020 | 7603 | 0.100 |
Why?
|
Hypercholesterolemia | 2 | 2016 | 1145 | 0.100 |
Why?
|
Migraine Disorders | 2 | 2016 | 1713 | 0.100 |
Why?
|
Child | 17 | 2023 | 80960 | 0.100 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 737 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.100 |
Why?
|
Calcitriol | 1 | 2014 | 303 | 0.100 |
Why?
|
Mendelian Randomization Analysis | 3 | 2023 | 1040 | 0.100 |
Why?
|
Ovariectomy | 1 | 2014 | 613 | 0.100 |
Why?
|
Nevus | 1 | 2014 | 205 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.100 |
Why?
|
Myocardial Revascularization | 1 | 2016 | 796 | 0.100 |
Why?
|
Dietary Proteins | 2 | 2014 | 960 | 0.100 |
Why?
|
Genotype | 5 | 2021 | 13048 | 0.100 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2015 | 410 | 0.100 |
Why?
|
Estriol | 1 | 2011 | 53 | 0.100 |
Why?
|
Fasting | 1 | 2018 | 1610 | 0.100 |
Why?
|
Mortality | 3 | 2019 | 2914 | 0.100 |
Why?
|
Ovarian Follicle | 2 | 2019 | 244 | 0.100 |
Why?
|
Uterine Neoplasms | 1 | 2020 | 1424 | 0.090 |
Why?
|
Prostatic Neoplasms | 3 | 2021 | 11230 | 0.090 |
Why?
|
Medical History Taking | 3 | 2021 | 779 | 0.090 |
Why?
|
Adenoma | 1 | 2022 | 2163 | 0.090 |
Why?
|
Vitamin E | 1 | 2015 | 874 | 0.090 |
Why?
|
Erythrocytes | 1 | 2020 | 2421 | 0.090 |
Why?
|
Data Collection | 1 | 2020 | 3324 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2431 | 0.090 |
Why?
|
Premature Birth | 1 | 2023 | 1830 | 0.090 |
Why?
|
Lactation | 1 | 2012 | 392 | 0.090 |
Why?
|
Melanoma | 2 | 2022 | 5709 | 0.090 |
Why?
|
Hearing Loss | 1 | 2017 | 785 | 0.090 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 2 | 2008 | 208 | 0.080 |
Why?
|
Male | 22 | 2023 | 365203 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9442 | 0.080 |
Why?
|
Acne Vulgaris | 1 | 2015 | 352 | 0.080 |
Why?
|
Estrogen Receptor alpha | 3 | 2018 | 581 | 0.080 |
Why?
|
Birth Weight | 2 | 2008 | 2121 | 0.080 |
Why?
|
Population Surveillance | 5 | 2017 | 2597 | 0.080 |
Why?
|
Overweight | 1 | 2020 | 2448 | 0.080 |
Why?
|
Canada | 2 | 2022 | 2130 | 0.080 |
Why?
|
Random Allocation | 1 | 2013 | 2394 | 0.080 |
Why?
|
Genome, Human | 1 | 2022 | 4456 | 0.080 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 2094 | 0.080 |
Why?
|
Ovary | 2 | 2019 | 965 | 0.080 |
Why?
|
Venous Thromboembolism | 2 | 2018 | 1881 | 0.080 |
Why?
|
Antidepressive Agents | 2 | 2017 | 2913 | 0.080 |
Why?
|
Citrus paradisi | 1 | 2007 | 9 | 0.080 |
Why?
|
Genetic Loci | 1 | 2017 | 2630 | 0.070 |
Why?
|
Milk, Human | 1 | 2012 | 490 | 0.070 |
Why?
|
Calcium | 1 | 2021 | 5792 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3810 | 0.070 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2020 | 2542 | 0.070 |
Why?
|
Health Behavior | 2 | 2019 | 2649 | 0.070 |
Why?
|
Molecular Structure | 1 | 2011 | 1885 | 0.070 |
Why?
|
Contraceptives, Oral | 2 | 2021 | 561 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3671 | 0.070 |
Why?
|
Precancerous Conditions | 1 | 2014 | 985 | 0.070 |
Why?
|
Somatomedins | 1 | 2007 | 179 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4363 | 0.070 |
Why?
|
Walking | 1 | 2014 | 1201 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3383 | 0.070 |
Why?
|
Premenstrual Syndrome | 1 | 2007 | 111 | 0.070 |
Why?
|
Human Development | 1 | 2007 | 122 | 0.070 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 2027 | 0.070 |
Why?
|
Hip Fractures | 1 | 2014 | 997 | 0.070 |
Why?
|
Air Pollution | 1 | 2020 | 2372 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2018 | 2085 | 0.070 |
Why?
|
Alleles | 3 | 2022 | 6901 | 0.070 |
Why?
|
Models, Theoretical | 2 | 2019 | 3580 | 0.060 |
Why?
|
Software | 1 | 2020 | 4479 | 0.060 |
Why?
|
Circadian Rhythm | 1 | 2017 | 2593 | 0.060 |
Why?
|
Sleep | 2 | 2023 | 4820 | 0.060 |
Why?
|
Forecasting | 1 | 2015 | 2945 | 0.060 |
Why?
|
Adiponectin | 2 | 2013 | 1117 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11116 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1515 | 0.060 |
Why?
|
Growth Hormone | 1 | 2007 | 573 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2015 | 5864 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13594 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3411 | 0.060 |
Why?
|
Asthma | 2 | 2020 | 6293 | 0.060 |
Why?
|
Anxiety | 1 | 2019 | 4672 | 0.060 |
Why?
|
Area Under Curve | 2 | 2019 | 1645 | 0.060 |
Why?
|
Regression Analysis | 1 | 2013 | 6346 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5801 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2019 | 4530 | 0.050 |
Why?
|
Smoking | 3 | 2018 | 9094 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4251 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8749 | 0.050 |
Why?
|
Kynurenine | 1 | 2023 | 142 | 0.050 |
Why?
|
Aging | 2 | 2021 | 8745 | 0.050 |
Why?
|
Age Distribution | 3 | 2017 | 2875 | 0.050 |
Why?
|
Time Factors | 6 | 2020 | 40261 | 0.050 |
Why?
|
Metabolic Networks and Pathways | 2 | 2019 | 800 | 0.050 |
Why?
|
Plasmalogens | 1 | 2022 | 30 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2017 | 12806 | 0.050 |
Why?
|
Causality | 2 | 2021 | 1256 | 0.050 |
Why?
|
Norgestrel | 1 | 2021 | 11 | 0.050 |
Why?
|
Desogestrel | 1 | 2021 | 18 | 0.050 |
Why?
|
Phosphatidylethanolamines | 1 | 2022 | 131 | 0.050 |
Why?
|
Benzene | 1 | 2022 | 106 | 0.050 |
Why?
|
Poultry | 1 | 2022 | 79 | 0.050 |
Why?
|
Calcifediol | 1 | 2023 | 160 | 0.050 |
Why?
|
Jews | 1 | 2023 | 359 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2848 | 0.050 |
Why?
|
Tryptophan | 1 | 2023 | 482 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2017 | 416 | 0.050 |
Why?
|
Levonorgestrel | 1 | 2021 | 80 | 0.050 |
Why?
|
Israel | 1 | 2023 | 726 | 0.050 |
Why?
|
Ethinyl Estradiol | 1 | 2021 | 114 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4056 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 3238 | 0.050 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2021 | 118 | 0.050 |
Why?
|
Formaldehyde | 1 | 2022 | 361 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3253 | 0.040 |
Why?
|
ROC Curve | 2 | 2019 | 3629 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 7861 | 0.040 |
Why?
|
Medicare | 1 | 2019 | 6888 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2021 | 3629 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15471 | 0.040 |
Why?
|
Child, Preschool | 3 | 2022 | 42683 | 0.040 |
Why?
|
Genetic Pleiotropy | 1 | 2021 | 181 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2017 | 4818 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6547 | 0.040 |
Why?
|
Mass Screening | 1 | 2015 | 5457 | 0.040 |
Why?
|
Progestins | 1 | 2021 | 302 | 0.040 |
Why?
|
Mutation | 3 | 2021 | 30266 | 0.040 |
Why?
|
Mites | 1 | 1999 | 46 | 0.040 |
Why?
|
Europe | 2 | 2017 | 3441 | 0.040 |
Why?
|
alpha-Amylases | 1 | 2019 | 39 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2022 | 6856 | 0.040 |
Why?
|
Particulate Matter | 2 | 2022 | 2615 | 0.040 |
Why?
|
Animals | 10 | 2022 | 169335 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2020 | 103 | 0.040 |
Why?
|
Trans Fatty Acids | 1 | 2020 | 155 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2020 | 148 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 2019 | 222 | 0.040 |
Why?
|
Intergenerational Relations | 1 | 2019 | 68 | 0.040 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 2019 | 133 | 0.040 |
Why?
|
Elasticity | 1 | 2021 | 657 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3952 | 0.040 |
Why?
|
Diglycerides | 1 | 2018 | 176 | 0.040 |
Why?
|
Human Growth Hormone | 2 | 2017 | 651 | 0.040 |
Why?
|
Lactose | 1 | 2018 | 95 | 0.040 |
Why?
|
International Agencies | 1 | 2019 | 244 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2019 | 239 | 0.040 |
Why?
|
Pedigree | 1 | 2006 | 4545 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2019 | 310 | 0.040 |
Why?
|
Cognition | 1 | 2016 | 7081 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2748 | 0.040 |
Why?
|
Glycoproteins | 2 | 2023 | 2202 | 0.040 |
Why?
|
Bronchial Hyperreactivity | 1 | 1999 | 301 | 0.040 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2019 | 276 | 0.040 |
Why?
|
Glutamine | 1 | 2021 | 578 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2020 | 168 | 0.040 |
Why?
|
Eczema | 1 | 2020 | 245 | 0.040 |
Why?
|
Follicular Phase | 1 | 2018 | 143 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 473 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 789 | 0.040 |
Why?
|
Carnitine | 1 | 2018 | 253 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2022 | 1104 | 0.040 |
Why?
|
Carcinoma, Endometrioid | 1 | 2020 | 277 | 0.040 |
Why?
|
Computational Biology | 2 | 2020 | 3562 | 0.030 |
Why?
|
Dipeptides | 1 | 2019 | 386 | 0.030 |
Why?
|
Models, Biological | 3 | 2020 | 9499 | 0.030 |
Why?
|
Wine | 1 | 2017 | 172 | 0.030 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2020 | 395 | 0.030 |
Why?
|
Cholesterol | 1 | 2005 | 2913 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4785 | 0.030 |
Why?
|
Amino Acids | 1 | 2022 | 1716 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10765 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6401 | 0.030 |
Why?
|
Anthropometry | 1 | 2020 | 1345 | 0.030 |
Why?
|
Asia | 1 | 2017 | 630 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2021 | 2000 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 300 | 0.030 |
Why?
|
Waist-Hip Ratio | 2 | 2007 | 520 | 0.030 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 480 | 0.030 |
Why?
|
Maternal Age | 1 | 2018 | 805 | 0.030 |
Why?
|
Homocysteine | 1 | 2019 | 637 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10633 | 0.030 |
Why?
|
Genomics | 2 | 2022 | 5928 | 0.030 |
Why?
|
Calcium, Dietary | 1 | 2018 | 533 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2021 | 1191 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 866 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.030 |
Why?
|
Reproduction | 1 | 2019 | 646 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 755 | 0.030 |
Why?
|
Creatine | 1 | 2016 | 427 | 0.030 |
Why?
|
Saliva | 1 | 2019 | 854 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2019 | 746 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2016 | 527 | 0.030 |
Why?
|
Nursing Staff | 1 | 2015 | 113 | 0.030 |
Why?
|
Cysteine | 1 | 2019 | 897 | 0.030 |
Why?
|
Amenorrhea | 1 | 2017 | 484 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2017 | 792 | 0.030 |
Why?
|
Television | 1 | 2016 | 410 | 0.030 |
Why?
|
SEER Program | 1 | 2019 | 1473 | 0.030 |
Why?
|
Politics | 1 | 2020 | 822 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2016 | 818 | 0.030 |
Why?
|
Calibration | 1 | 2016 | 822 | 0.030 |
Why?
|
Fragaria | 1 | 2013 | 21 | 0.030 |
Why?
|
Placental Hormones | 1 | 2012 | 11 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9549 | 0.030 |
Why?
|
Hydroxyestrones | 1 | 2012 | 17 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2020 | 1758 | 0.030 |
Why?
|
Haplotypes | 1 | 2019 | 2725 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 2133 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2021 | 6236 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.020 |
Why?
|
Radiography | 2 | 2013 | 6991 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11521 | 0.020 |
Why?
|
North America | 1 | 2015 | 1290 | 0.020 |
Why?
|
Air Pollution, Indoor | 1 | 1999 | 931 | 0.020 |
Why?
|
Transcription Factors | 2 | 2023 | 12174 | 0.020 |
Why?
|
Carcinogens | 1 | 2013 | 453 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1752 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2019 | 1841 | 0.020 |
Why?
|
Sheep | 1 | 2013 | 1451 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2023 | 26428 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1968 | 0.020 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2020 | 1399 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2798 | 0.020 |
Why?
|
Sports | 1 | 2016 | 703 | 0.020 |
Why?
|
Hormone Replacement Therapy | 1 | 2016 | 757 | 0.020 |
Why?
|
Immunoassay | 1 | 2013 | 746 | 0.020 |
Why?
|
Genetic Testing | 1 | 2023 | 3591 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3626 | 0.020 |
Why?
|
Genital Neoplasms, Female | 1 | 2015 | 538 | 0.020 |
Why?
|
Ethanol | 1 | 2015 | 1331 | 0.020 |
Why?
|
Binding Sites | 1 | 2017 | 6023 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2974 | 0.020 |
Why?
|
Registries | 2 | 2014 | 8384 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12430 | 0.020 |
Why?
|
Cattle | 1 | 2013 | 3819 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2022 | 81903 | 0.020 |
Why?
|
Climacteric | 1 | 2007 | 57 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 812 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3110 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5804 | 0.020 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2015 | 1376 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 937 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12873 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2680 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2604 | 0.020 |
Why?
|
Memory | 1 | 2016 | 2209 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4095 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2714 | 0.020 |
Why?
|
Postpartum Period | 1 | 2012 | 1198 | 0.020 |
Why?
|
Models, Genetic | 1 | 2015 | 3449 | 0.020 |
Why?
|
Mitochondria | 1 | 2019 | 3682 | 0.020 |
Why?
|
Health Care Costs | 1 | 2019 | 3270 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4940 | 0.020 |
Why?
|
Androstenedione | 1 | 2004 | 132 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3235 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6805 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6291 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9527 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7148 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3859 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2483 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11932 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 9080 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3709 | 0.010 |
Why?
|
Blood Pressure | 1 | 2016 | 8544 | 0.010 |
Why?
|
Beclomethasone | 1 | 1999 | 38 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15879 | 0.010 |
Why?
|
Triamcinolone | 1 | 1999 | 68 | 0.010 |
Why?
|
Methacholine Chloride | 1 | 1999 | 220 | 0.010 |
Why?
|
Cromolyn Sodium | 1 | 1999 | 78 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13674 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2012 | 2666 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8094 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36556 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23653 | 0.010 |
Why?
|
Dust | 1 | 1999 | 488 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 1999 | 1694 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 14201 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 1999 | 577 | 0.010 |
Why?
|
Antigens | 1 | 1999 | 1444 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18354 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14752 | 0.010 |
Why?
|
Allergens | 1 | 1999 | 1444 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 1999 | 1811 | 0.010 |
Why?
|